Malignant mesothelioma
2008
Understanding Malignant Mesothelioma
publication
Evidence: moderate
Author Information
Author(s): Alastair J Moore, Robert J Parker, John Wiggins
Primary Institution: Department of Respiratory Medicine, Wexham Park Hospital, Wexham, Slough, Berkshire, UK
Conclusion
Malignant mesothelioma is a serious cancer primarily caused by asbestos exposure, with a poor prognosis and various treatment options.
Supporting Evidence
- Malignant mesothelioma is directly linked to asbestos exposure in over 90% of cases.
- The incidence of mesothelioma is expected to peak in the next 10-20 years.
- Life expectancy for patients diagnosed with malignant mesothelioma is typically around one year.
Takeaway
Malignant mesothelioma is a type of cancer that usually happens because of asbestos exposure, and it can be very hard to treat.
Limitations
The study does not provide specific limitations but acknowledges the challenges in diagnosing and treating mesothelioma.
Participant Demographics
The disease primarily affects adults, with 70-80% of cases occurring in men, typically presenting in their 50s to 70s.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website